Sionna Therapeutics

Natick, United States

Sionna Therapeutics is developing novel small molecule therapies to treat cystic fibrosis (CF).

Mar 2024

Series C

Biotechnology Genetics Health Care Medical Pharmaceutical

Top Investors

RA Capital ManagementPerceptive AdvisorsOrbiMedAtlas VentureThe Rise Fund

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Sionna Therapeutics

Who are Sionna Therapeutics's investors?

Sionna Therapeutics's investors include RA Capital Management, Perceptive Advisors, OrbiMed, Atlas Venture, The Rise Fund.

Where is Sionna Therapeutics headquartered?

Sionna Therapeutics is headquartered in Natick, United States.

What does Sionna Therapeutics do?

Sionna Therapeutics is developing novel small molecule therapies to treat cystic fibrosis (CF).

What stage is Sionna Therapeutics at?

Sionna Therapeutics is at the Series C stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 6, 2024.

MLA

"Sionna Therapeutics — Funding & Investors." VCBacked, March 6, 2024, https://www.vcbacked.co/company/sionna-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2024). Sionna Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/sionna-therapeutics

Wikipedia (cite web)

{{cite web |title=Sionna Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/sionna-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 6, 2024.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver

Rapport Therapeutics

Boston

Neuroglee Therapeutics

Singapore

Living In Silico Inc.